Investing in mRNA Technologies
David Maza, Managing Director and Head of Product at Direxion, joins Cheddar News to discuss the evolution of mRNA technologies, future applications of this tech including fighting Lyme disease and HIV, and what this all means for investors.
More Videos
Fed Rate Cut In Focus: Is Inflation Too Hot For Powell To Move?
Chris Versace breaks down the mixed inflation and jobs data facing the Fed and what this week’s rate decision could mean for markets and 2027.
How PopSockets Went From A Garage Project To A Household Name
PopSockets founder David Barnett explains how a simple idea became 300 million products, major partnerships and a global phone-accessory brand.
Hollywood’s $4.7 Billion Summer: Is The Movie Business Back?
Seth Schachner, Managing Director at Strat Americas, explains what fueled Hollywood’s $4.7 billion summer and whether movie theaters are truly back.
The AI Safety Crisis Is Growing: Why Researchers Are Speaking Out
Christopher Zara, News Director at Fast Company, joins us as AI researchers raise new concerns about safety, control and the race to build powerful AI.
Trump Makes A Crypto Concession, But The Senate Fight Isn’t Over
President Trump has agreed to new ethics provisions aimed at clearing a major cryptocurrency bill through the Senate.
The Real Cost Of Owning A Car Today
New car owner analysis from Insurify finds drivers spend an average of $5,851 a year on insurance, gas and maintenance alone, separate from financing costs.
